Abstract:Objective: Obesity-related chronic inflammation plays an important role in the development of Metabolic Associated Fatty Liver Disease (MAFLD). Although the contribution of the pro-inflammatory NF-κB signaling pathway to the progression from simple steatosis to non-alcoholic steatohepatitis (NASH) is well-established, its role as an initiator of hepatic steatosis and the underlying mechanism remains unclear. Here, we investigated the hypothesis that the hepatocytic NF-κB signaling pathway acts as a metabolic regulator, thereby promoting hepatic steatosis development. Methods: A murine model expressing a constitutively active form of IKKβ in hepatocytes (Hep-IKKβca) was used to activate hepatocyte NF-κB. In addition, IKKβca was also expressed in hepatocyte A20-deficient mice (IKKβca;A20LKO). A20 is an NF-κB-target gene that inhibits the activation of the NF-κB signaling pathway upstream of IKKβ. These mouse models were fed a sucrose-rich diet for 8 weeks. Hepatic lipid levels were measured and using [1-13C]-acetate de novo lipogenesis and cholesterol synthesis rate were determined. Gene expression analyses and immunoblotting were used to study the lipogenesis and cholesterol synthesis pathways. Results: Hepatocytic NF-κB activation by expressing IKKβca in hepatocytes resulted in hepatic steatosis without inflammation. Ablation of hepatocyte A20 in Hep-IKKβca mice (IKKβca;A20LKO mice) exacerbated hepatic steatosis, characterized by macrovesicular accumulation of triglycerides and cholesterol, and increased plasma cholesterol levels. Both De novo lipogenesis (DNL) and cholesterol synthesis were found elevated in IKKβca;A20LKO mice. Phosphorylation of AMP-activated kinase (AMPK) - a suppressor in lipogenesis and cholesterol synthesis - was decreased in IKKβca;A20LKO mice. This was paralleled by elevated protein levels of hydroxymethylglutaryl-CoA synthase 1 (HMGCS1) and reduced phosphorylation of HMG-CoA reductase (HMGCR) both key enzymes in the cholesterol synthesis pathway. Whereas inflammation was not observed in young IKKβca;A20LKO mice sustained hepatic NF-κB activation resulted in liver inflammation, together with elevated hepatic and plasma cholesterol levels in middle-aged mice. Conclusions: The hepatocytic IKK:NF-κB axis is a metabolic regulator by controlling DNL and cholesterol synthesis, independent of its central role in inflammation. The IKK:NF-κB axis controls the phosphorylation levels of AMPK and HMGCR and the protein levels of HMGCS1. Chronic IKK-mediated NF-κB activation may contribute to the initiation of hepatic steatosis and cardiovascular disease risk in MAFLD patients.

Hepatic NF-kB-inducing Kinase (NIK) Suppresses Liver Regeneration in Chronic Liver Disease

Hepatic NF-kB-inducing Kinase (NIK) Suppresses Mouse Liver Regeneration in Acute and Chronic Liver Diseases

Thymic NF-κB-inducing Kinase Regulates CD4+ T Cell-Elicited Liver Injury and Fibrosis in Mice.

Liver NF-κB-Inducing Kinase Promotes Liver Steatosis and Glucose Counterregulation in Male Mice with Obesity

Mouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis.

Carboxyl Terminus of HSC70-interacting Protein (CHIP) Down-regulates NF-κB-inducing Kinase (NIK) and Suppresses NIK-induced Liver Injury*

Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit Α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury

NIK Links Inflammation to Hepatic Steatosis by Suppressing PPARα in Alcoholic Liver Disease.

Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.

A small-molecule inhibitor of NF-κB-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury.

The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis

Medullary Thymic Epithelial NF-kB-inducing Kinase (nik)/ikkα Pathway Shapes Autoimmunity and Liver and Lung Homeostasis in Mice.

Hepatocyte Growth Factor Suppresses Proinflammatory Nf Kappa B Activation Through Gsk3 Beta Inactivation In Renal Tubular Epithelial Cells

CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice

NIK-mediated Reactivation of SIX2 Enhanced the CSC-like Traits of Hepatocellular Carcinoma Cells Through Suppressing Ubiquitin-Proteasome System

Enhanced Liver Regeneration Following Changes Induced by Hepatocyte-Specific Genetic Ablation of Integrin-Linked Kinase

Moderate Activation of IKK2-NF-kB in Unstressed Adult Mouse Liver Induces Cytoprotective Genes and Lipogenesis Without Apparent Signs of Inflammation or Fibrosis.

Noncanonical NF-κB Signaling Pathway in Liver Diseases

Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo

Ahnak depletion accelerates liver regeneration by modulating the TGF-β/Smad signaling pathway

Hepatocyte Nuclear Factor 1A Suppresses Innate Immune Response by Inducing Degradation of TBK1 to Inhibit Steatohepatitis